Go to the Indico Home Page Oldest event Older event Up to category Newer event Newest event
  • Indico style
  • Indico style - inline minutes
  • Indico style - numbered
  • Indico style - numbered + minutes
  • Indico Weeks View
    • Switch to the management area of this event
    Login

    AOFSRR 2015 in conjunction with User Meeting 2015

    25–27 Nov 2015
    National Centre for Synchrotron Science
    Australia/Melbourne timezone

    Session

    Radiotherapy and Radiobiology

    26 Nov 2015, 11:00
    National Centre for Synchrotron Science

    National Centre for Synchrotron Science

    Australian Synchrotron 800 Blackburn Road Clayton VIC 3168

    Conveners

    Radiotherapy and Radiobiology

    • Jeff Crosbie (RMIT)

    Presentation materials

    There are no materials yet.

    1. 85. The innate immune system is associated with gene expression modulation in skin distant from irradiated sites.
      Dr Helen Forrester (Hudson Institute of Medical Research)
      26/11/2015, 11:00
      Radiotherapy and Radiobiology
      Oral
      Microbeam radiotherapy (MRT) utilizes high intensity synchrotron generated X-rays collimated planar microbeams (~25 µm). MRT showns promise for cancer treatment, effectively ablating tumours while causing less normal tissue damage compared to conventional broadbeam (BB) radiotherapy. Synchrotron radiation also has low scattering making it ideal to investigate non-targeted, systemic radiation...
      Go to contribution page
    2. 146. Nanoparticle Dose Enhancement of Synchrotron Beams on the IMBL
      Mr Frank Gagliardi (William Buckland Radiotherapy Centre)
      26/11/2015, 11:30
      Radiotherapy and Radiobiology
      Oral
      Nanoparticles with high atomic number (Z) have a larger x-ray cross section than biological tissues. Synchrotron beams interact with the nanoparticles to produce Auger electrons which deposit their energy over a short range, typically less than a micron. This characteristic offers the ability to enhance the dose delivered to tumors by synchrotron broad beam (BB) or microbeam radiation therapy...
      Go to contribution page
    3. 115. The Eclipse™ treatment planning system for microbeam radiotherapy trials at the Australian Synchrotron
      Dr Jeffrey CROSBIE (RMIT University)
      26/11/2015, 11:50
      Radiotherapy and Radiobiology
      Oral
      Before clinical trials of synchrotron microbeam radiotherapy (MRT) on humans can occur, a computerised treatment planning system (TPS) to calculate the dose distribution in the patient must be developed and validated. To satisfy this requirement, we use a research licenced version of the Eclipse™ TPS from Varian Medical Systems. This research license allows for customised dose calculation...
      Go to contribution page
    4. 46. Local and Abscopal Inflammatory Response to Synchrotron Radiation
      Mr Jason Palazzolo (Molecular Radiation Biology Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia)
      26/11/2015, 12:10
      Radiotherapy and Radiobiology
      Oral
      Microbeam radiation therapy (MRT) is a promising modality for administering synchrotron-generated ionizing radiation (IR). Compared to conventionally used broadbeam (BB) radiation, MRT yields improved therapeutic benefits by preserving healthy tissues whilst selectively ablating tumours. By offering beam precision and reduced radiation scattering, the Australian Synchrotron (AS) is ideal for...
      Go to contribution page
    Building timetable...